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in translocation: SecA recognizes both the leader sequence
and as yet unidentified motifs in the mature domain of the
preprotein (9, 11, 12). SecA interacts with SecB, thereby
assisting with protein targeting (8). SecA also promotes functional interactions between preprotein and translocation sites
in the inner membrane through its affinity for SecYEG and the
acidic phospholipids of the membrane (8, 9). Translocation of
20–30 residues of the preprotein across the membrane occurs
when SecA, in contact with a preprotein, SecYEG, and acidic
phospholipids, binds ATP. Hydrolysis of the bound ATP then
releases the preprotein from SecA, allowing the electrochemical proton gradient (proton motive force) to drive further
translocation. Translocating proteins undergo many such cycles of SecA binding, ATP binding to SecA, limited translocation, ATP hydrolysis, and preprotein release from SecA,
followed by proton motive force-driven translocation (13, 14).
Many aspects of how SecA couples the energy of ATP
binding to the translocation of preprotein across the bacterial
inner membrane remain unclear. In the presence of SecYEG,
preprotein, and bound ATP, a 30-kDa domain of SecA inserts
into the plane of the membrane where it is protected from
proteases added to the cytoplasmic membrane surface (15) as
well as to photoactivatable probes dissolved in the lipid phase
(16). Cycles of SecA membrane insertionydeinsertion may be
responsible for the forward movement of a translocating
polypeptide chain across the membrane. Indeed, cross-linking
techniques have shown that the preprotein crosses in association with SecA throughout its membrane passage (17). We
now report that an N-terminal 65-kDa domain of the 102-kDa
SecA protein is protected from proteolytic digestion under the
same translocation conditions required for protease protection
of a C-terminal 30-kDa domain. Furthermore, both SecA
domains participate in membrane insertionydeinsertion cycles
at SecYEG sites. Since the high-affinity nucleotide-binding
domain (18, 19) as well as a proposed site of preprotein binding
(12) are contained within this N-terminal domain of SecA,
conformational changes of this domain are likely to be of
central importance to preprotein movement.

ABSTRACT
SecA, a 102-kDa hydrophilic protein, couples
the energy of ATP binding to the translocation of preprotein
across the bacterial inner membrane. SecA function and
topology were studied with metabolically labeled [35S]SecA
and with inner membrane vesicles from cells that overexpressed SecYEGDFyajC, the integral domain of preprotein
translocase. During translocation in the presence of ATP and
preprotein, a 65-kDa N-terminal domain of SecA is protected
from proteolytic digestion through insertion into the membrane, as previously reported for a 30-kDa C-terminal domain
[Economou, A. & Wickner, W. (1994) Cell 78, 835–843].
Insertion of both domains occurs at saturable SecYEGDFyajC
sites and is rapidly followed by deinsertion. SecA also associates nonsaturably and unproductively with lipid. In the
presence of ATP, yet without involvement of preprotein or
SecYEG, lipid-bound SecA forms domains that are proteaseresistant and that remain so even upon subsequent membrane
disruption. Unlike the [35S]SecA that inserts into the membrane at SecYEGDFyajC as it promotes preprotein translocation, lipid-associated [35S]SecA does not chase from its
protease-resistant state upon the addition of excess SecA. The
finding that two domains of SecA (which together represent
most regions of the polypeptide chain) cycle into the membrane during preprotein translocation, as well as the distinction between the membrane association of SecA at translocation sites of SecYEGDFyajC and at nonproductive lipid sites,
are fundamental to the study of the role of SecA in preprotein
movement.
Pathways of protein targeting and translocation into noncytoplasmic compartments have been examined in various eukaryotic organelles, including the mitochondria, nucleus, and endoplasmic reticulum, as well as in bacteria (1). With their
unparalleled ease of combining biochemistry and genetics,
bacteria offer unique advantages for addressing questions of
protein translocation (2–5). In Escherichia coli, most protein
translocation across the inner membrane occurs posttranslationally, catalyzed by a multicomponent secretory apparatus
consisting of the cytosolic, export-specific SecB chaperone, the
ATPase protein SecA, and the membrane-embedded heterotrimeric SecYEG complex (6–9). Recent studies have shown
that SecDFyajC can be isolated with SecYEG as part of a
larger membrane-embedded complex, termed SecYEGDFyajC (10). SecA plays a pivotal role in bacterial protein export
by interacting with most, if not all, of the components involved
Copyright q 1997 by THE NATIONAL ACADEMY OF SCIENCES
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OF THE

MATERIALS AND METHODS
Materials. SecA (20), SecB (6), and proOmpA (21) were
prepared as described. Adenylyl-imidophosphate, ampicillin,
ATP, 2-mercaptoethanol, chymotrypsin, DTT, soybean trypsin inhibitor, and trypsin were from Sigma; creatine kinase,
creatine phosphate, isopropylthio-b-D-galactopyranoside, pro-

USA

*To whom reprint requests should be addressed. e-mail:
william.wickner@dartmouth.edu.

5574

Biochemistry: Eichler and Wickner
teinase K, and Staphylococcus aureus V8 were from Boehringher Mannheim; P11 cellulose phosphate was from Whatman;
and [35S]Express protein-labeling mixture and [125I]Na were
from Amersham. [125I]SecA (16) was prepared as described.
Cell Growth, [35S]Metabolic Labeling, and Purification of
35
[ S]SecA. The E. coli SecA overproducing strain BL21
(lDE3)ypT7-secA (22) was grown with aeration at 378C in 100
ml of M9 medium (23), 1 mgyml thiamine, 0.2% glucose, 0.5%
amino acids (lacking methionine and cysteine), and 50 mgyml
ampicillin (20). At OD600 5 0.5 the cells were induced with 0.5
mM isopropylthio-b-D-galactopyranoside for 30 min, after
which 2 mCi (1 Ci 5 37 GBq) of [35S]Express protein-labeling
mixture were added. Growth was continued for an additional
60 min. The cells were then harvested (3,000 3 g at 48C for 5
min), resuspended in 1 ml of 10% sucrosey50 mM TriszHCl
(pH 7.5), and frozen in liquid N2.
Purification of [35S]SecA was based on the procedure of
Cunningham et al. (20). Thawed cells (500 ml) were treated
with lysozyme (5 ml, 8 mgyml) for 30 min on ice followed by
3 min at 378C without shear. The suspension was centrifuged
(30,000 rpm for 20 min at 48C in a TL 120.2 rotor; Beckman
Optima TLX ultracentrifuge), and the supernatant was applied
to a P11 cellulose phosphate column (0.7 3 2 cm), equilibrated
in 10 mM sodium phosphate, pH 6.5. After washing with 20 ml
of this buffer, [35S]SecA was eluted with a 20-ml linear gradient
of 0.1–0.5 M sodium phosphate, pH 6.5. Fractions (0.5 ml)
were collected and the position of the eluted [35S]SecA peak
was determined by scintillation counting and confirmed by
SDSyPAGE and fluorography. The specific activity of the
purified [35S]SecA was 1.95 3 105 cpmymg.
Inner Membrane Vesicles (IMVs). Inner membrane vesicles
were prepared as previously described (24) from E. coli BL21
that was genetically altered to overexpress SecYEGDFyajC
(10), from BL21ypHAsecEYG, an overproducer of SecYEG
(24), from wild-type BL21 and from E. coli KM9 (unc-::tn10,
relA1, spoT1, metB1; ref. 25). The membranes were treated
with 6 M urea (30 min at 08C) to remove and inactivate
endogenous SecA (20).
Formation of Membrane-Inserted SecA. For formation of
the protease-protected SecA domains, 10 ml of 103 buffer B
(500 mM KCly10 mM DTTy500 mM TriszHCl, pH 7.9), 3 mg
SecB, water, 1 ml [125I]SecA (100,000 cpmyml) or 20 ml
[35S]SecA (5,000 cpmyml), an ATP regenerating system (1 mg
creatine kinase and 2 ml of 0.5 M phosphocreatine), 10 mg
IMVs (or liposomes), 1 ml proOmpA [1.5 mgyml in urea buffer
(6 M ureay1 mM DTTy50 mM TriszHCl, pH 7.9)], and 5 ml of
0.1 M ATP were added in sequence to a final reaction volume
of 0.1 ml and incubated at 378C for 30 min. After transfer to
ice, the samples were digested with 10 ml of trypsin (10 mgyml)
for 15 min. The samples were then incubated with 15%
trichloroacetic acid (TCA) for 30 min on ice, centrifuged at 48C
in a microfuge, suspended in 1 ml of ice-cold acetone, collected
by centrifugation, dissolved in 30 ml of sample buffer containing 2-mercaptoethanol (26), and examined by SDSyPAGE and
autoradiography or fluorography.
Limited Proteolytic Digestion of SecA in Solution. SecA was
cleaved into a characteristic set of proteolytic fragments (27)
as follows: 15 mg of SecA, in some experiments with either
[125I]SecA or [35S]SecA, was incubated with 0–25 mgyml of
trypsin in a final volume of 0.1 ml for 15 min on ice. Proteolysis
was terminated by the addition of 0.5 mgyml soybean trypsin
inhibitor. The protein fragments were then TCA precipitated
and acetone ‘‘washed’’ as above, heated in sample buffer (3
min, 958C), and examined by SDSyPAGE. The gels were then
stained with Coomassie brilliant blue and dried, and those
samples containing radioactive SecA were exposed to film
(X-Omat, Kodak).
One-Dimensional Peptide Mapping. One-dimensional peptide maps were prepared essentially according to Cleveland et
al. (28). [35S]SecA was subjected to limited trypsinolysis in
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solution or used in translocation reactions, both as described
above, and examined by SDSyPAGE. After Coomassie staining and destaining, gel regions containing the 65-kDa fragment
were excised and incubated with buffer P (1 mM EDTAy0.1%
SDSy125 mM TriszHCl, pH 6.8) (10 ml, 30 min). Individual gel
slices were then added to the bottoms of the wells of a second
gel and overlayed with 10 ml of buffer P containing 20%
glycerol. Finally, 10 ml of a solution of buffer P containing 10%
glycerol and 0–0.1 mg of S. aureus V8 were added to the wells,
and SDSyPAGE was performed as normal except that the
current was shut off for 30 min when the bromphenol blue dye
front approached the bottom of the stacking gel. The resulting
peptide maps were examined by fluorography.
Other Methods. Protein concentrations were determined
using Bradford reagent (Bio-Rad) with BSA as a standard.
SDSyPAGE was performed using 15% gels. Densitometry was
performed using a Silverscan III scanner (LaCie, Beaverton,
OR) and IPLabH software.

RESULTS
[35S]SecA

Radiolabel in
Is Evenly Distributed Throughout
the Protein. Limited tryptic digestion of SecA (102 kDa) leads
to the generation of a limited number of major proteolytic
fragments of apparent molecular masses of 65, 48, 38, and 30
kDa (27) (Fig. 1 Top). Amino acid sequencing of the 65-kDa
and 30-kDa fragments has shown them to begin at residues 5
and 611 of the SecA polypeptide, respectively (27, 29). When
[125I]SecA was subjected to identical limited proteolysis, radioactivity was almost exclusively found in the 38-kDa fragment at lower trypsin concentrations, and in the 30-kDa
fragment at higher protease levels (Fig. 1 Middle). This is
surprising, since the amino acid sequence of SecA reveals an
even distribution of tyrosyl residues, the targets of radioiodination (29). This suggests that only tyrosyl residues in the
C-terminal third of the protein are accessible for radioiodination. [125I]iodination of SecA in the presence of denaturing
agents such as 6 M urea or 8 M guanidine hydrochloride
prevented proper SecA refolding (not shown). Therefore, to
provide an even distribution of radiolabel throughout properly
folded SecA, cells genetically programmed to overproduce
SecA were grown in the presence of 35S-labeled methionine
and cysteine. SecA contains an even distribution of these
sulfur-containing residues throughout its sequence (29). Purification and limited trypsin digestion of the metabolically
labeled [35S]SecA confirmed that the radiolabel had been
incorporated throughout the protein (Fig. 1 Bottom). As
expected, [35S]SecA was fully functional in preprotein translocation reactions (not shown).
A 65-kDa Domain of SecA Becomes Protected from Protease
During Preprotein Translocation. We have reported that
SecA, upon incubation with inverted inner membrane vesicles,
preprotein, and nucleotide, inserts a C-terminal 30-kDa domain into the membrane, where it is protected from proteolytic
digestion (15, 27). These studies used [125I]SecA and, therefore, because of the biased distribution of the [125I] label,
detected no other protease-protected domains of SecA. To
determine whether any other portions of SecA are protected
from proteolytic digestion, SecA insertion reactions were
performed using [35S]SecA (Fig. 2A). In the absence of
membranes, preprotein, or nucleotide, [35S]SecA, a 102-kDa
protein (lane 1), is digested to small peptides by trypsin (1
mgyml, 15 min on ice; lane 2). However, in translocation
reactions conducted at physiological temperature with IMVs,
the precursor of outer membrane protein A (proOmpA), and
ATP, both a 65-kDa domain of [35S]SecA (solid arrow) and the
expected 30-kDa domain (open arrow) were protected from
externally added trypsin (lane 3). As for the 30-kDa domain,
protection of the 65-kDa SecA domain from proteolysis was
not observed in the absence of ATP or proOmpA (lanes 4 and
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FIG. 1. Radiolabel distribution in SecA. A limited trypsin digest of
SecA (15 mg) in solution was performed using 0–25 mgyml trypsin. The
proteolytic fragments were analyzed by SDSyPAGE and stained with
Coomassie brilliant blue (Top). In some cases, either [125I]SecA or
[35S]SecA was included in the trypsin digest reaction and the resulting
proteolytic pattern was detected by autoradiography or fluorography
(Middle and Bottom, respectively). The molecular masses of the major
digestion products are shown on the right.

5, respectively) or when the reaction was conducted on ice (not
shown). The requirement for SecYEG in the protection of the
65-kDa domain from proteolysis was confirmed by using
liposomes in place of IMVs (lanes 6–8). Strikingly, when ATP
as well as IMVs or liposomes were present, additional SecA
fragments survived the proteolytic treatment (asterisks).
These SecA fragments cannot, however, be related to translocation since their appearance was not dependent on the
presence of preprotein or SecYEG (lanes 5 and 6 and lane 8,
respectively) or physiological temperature (not shown). Because their appearance did, however, require that either IMVs
or liposomes be present in addition to nucleotide, these
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FIG. 2. A 65-kDa domain of SecA is protected from proteolysis
under translocation conditions. (A) The effect of trypsin treatment (1
mgyml, 15 min, 08C) on [35S]SecA was examined in the absence of
membranes (lane 2) or in translocation reactions with either IMVs
prepared from cells genetically enriched in SecYEGDFyajC [the
integral membrane domain of preprotein translocase holoenzyme
(10); lanes 3–5] or liposomes (lanes 6–8), as described. Reaction
mixtures contained proOmpA and ATP (lanes 3 and 6) or either
proOmpA or ATP alone (lanes 4 and 7 or 5 and 8, respectively). (B)
The profile of protease-resistant [35S]SecA domains generated under
translocation conditions was examined with 0–10 mgyml trypsin. For
each lane, the black arrow identifies the protease-protected SecA
65-kDa domain and the white arrow identifies the protease-protected
SecA 30-kDa domain; molecular mass markers are shown on the right.

fragments may correspond to proteolytic digestion products of
SecA conformationally altered by its associations with lipid
and ATP. As previously reported for the 30-kDa domain of
[125I]SecA (15), the 65-kDa and 30-kDa [35S]SecA domains
were also protected from proteolysis in the presence of IMVs
and adenylyl-imidophosphate, a nonhydrolyzable ATP analog
(not shown). Furthermore, the translocation-related 65-kDa
and 30-kDa membrane-inserted SecA domains, as well as
many lipid-associated SecA domains, could be protected from
trypsin concentrations of up to 10 mgyml (Fig. 2B). Similar
results were obtained when proteolysis was performed using
chymotrypsin or proteinase K instead of trypsin (not shown).
Identification of the Protease-Protected 65-kDa SecA Domain. Because the protease-protected 65-kDa SecA domain
was not observed in translocation reactions using C-terminally
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radiolabeled [125I]SecA (15), it seems unlikely that the protease-protected C-terminal 30-kDa domain is contained within
the larger 65-kDa domain, but, rather, that the two represent
unique portions of the 102-kDa SecA polypeptide. If this is
indeed the case, then the 65-kDa protease-protected SecA
domain would originate near the N terminus of the polypeptide. Amino acid sequencing of the 65-kDa fragment generated
upon limited tryptic digestion of SecA showed this fragment to
begin at the fifth amino acid residue of SecA (27). To
determine whether the 65-kDa protease-protected fragment
obtained from translocation reactions that contained
[35S]SecA (Fig. 3, lane 2) corresponds to the 65-kDa fragment
obtained from a limited trypsinolysis of [35S]SecA in solution
(Fig. 3, lane 1), peptide mapping of each was performed using
S. aureus V8 (Fig. 3). The almost identical digestion patterns
confirm that the translocation-related protease-protected
SecA 65-kDa domain originates near the N terminus.
As an independent means of mapping the proteaseprotected SecA 65-kDa domain, it was determined that affinity-purified anti-peptide antibodies to the N-terminal amino
acid residues 8–20 (but not those to the C-terminal amino acid
residues 877–890) recognized, albeit weakly, the 65-kDa band
from complete translocation reactions containing IMVs,
proOmpA, and ATP (not shown). The assignment of the band
recognized by the SecA N-terminal antibodies as the 65-kDa
protease-protected fragment was established by its absence
when the translocation reactions were performed without
either ATP or proOmpA.
Protease-Protection of the SecA 65-kDa Domain Occurs at
SecYEG. SecYEG is essential for the generation of both the
SecA 65-kDa and 30-kDa protease-protected domains (see
Fig. 2 A; also ref. 15 and 24). To confirm that protection occurs
at these sites, translocation experiments were performed with
IMVs from cells that overexpress SecY, SecE, SecG, SecD,
SecF, and YajC, integral membrane polypeptides of preprotein
translocase holoenzyme (10), or IMVs from BL21 wild-type
cells. [35S]SecA was mixed with increasing amounts of unlabeled SecA before being added to translocation reactions as a
measure of the abundance of SecA insertion sites. In both
cases, nonradioactive SecA competed with [35S]SecA for insertion sites that allow the formation of 65-kDa and 30-kDa
protease-protected domains (Fig. 4 A and B). Quantitation of
these data (Fig. 4C) shows that overexpression of SecYEGD-

FIG. 3. The protease-protected SecA 65-kDa domain lies near the
N terminus of the protein. The [35S]SecA 65-kDa fragments resulting
from limited trypsin treatment of SecA in solution (S, lanes 1, 3, 5, and
7) or protected from tryptic digestion under translocation conditions
(TL, lanes 2, 4, 6, and 8) were analyzed by peptide mapping using S.
aureus V8, as described. The black arrow identifies the position of the
SecA 65-kDa domain.
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FyajC provides additional sites for SecA membrane insertion,
which leads to the formation of 65-kDa and 30-kDa fragments.
Moreover, nonradioactive SecA competes in an identical
fashion for the formation of the 65-kDa and 30-kDa proteaseprotected fragments in either membrane preparation. Thus,
these data show that insertion of SecA at SecYEGDFyajC sites
leads to protease-protection of both the 65-kDa and 30-kDa
domains. The results also confirm that the binding and insertion of SecA at lipid sites (Fig. 4A, asterisks) lead, upon
proteolysis, to the formation of other protease-protected frag-

FIG. 4. Protease protection of the SecA 65-kDa domain occurs at
SecYEGDFyajC sites. [35S]SecA (5 3 104 cpm) was mixed with
increasing amounts of unlabeled SecA (0–75 mg) and used in translocation reactions with IMVs (10 mg) from either SecYEGDFyajCoverexpressing cells (A) or wild-type cells (B), as described. For each
lane, the black arrow identifies the protease-protected SecA 65-kDa
domain and the white arrow identifies the protease-protected SecA
30-kDa domain; molecular mass markers are shown on the right. The
expanded area of the gel serves to distinguish between the proteaseprotected 30-kDa fragment and a slightly larger band that is not related
to translocation. (C) The radioactivity in protease-protected SecA
65-kDa and 30-kDa domains were determined densitometrically and
expressed as a percentage of the amount of these fragments obtained
in translocation reactions using [35S]SecA alone.
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ments (see Fig. 2 A). Lipid association of SecA is nonsaturable
(8), as shown by the failure of nonradioactive SecA to compete
for sites of formation of these fragments (Fig. 4 A and B).
Furthermore, the SecA 65-kDa and 30-kDa domains formed
using IMVs from either the BL21 wild-type strain or the
SecYEGDFyajC-overexpressing strain are protected from
proteolytic degradation, confirming that the protection is not
the result of the overexpression of the membrane-embedded
Sec proteins. Indeed, the 65-kDa and 30-kDa proteaseprotected fragments could also be generated using IMVs from
E. coli strain KM9 (see below).
The 65-kDa Protease-Protected SecA Domain Inserts into
the Membrane. To determine whether the protease resistance
of the SecA 65-kDa fragment was due to a protease-resistant
conformation of SecA (assumed upon interaction with SecYEGDFyajC, ATP, and preprotein) or rather due to insertion
into the membrane as reported for the protease-protected
SecA 30-kDa domain (15), 1% Triton X-100 was added to
translocation reactions containing [35S]SecA just prior to the
addition of trypsin. Detergent disruption of membrane integrity allowed digestion of both the SecA 65-kDa and the 30-kDa
domains (Fig. 5, lane 2). Protease-resistant SecA fragments of
38, 28, and 21 kDa (asterisks) were unaffected by the disruption of the membrane. Lipid association was required for the
SecA conformational changes leading to the generation of
these fragments, since complete digestion of SecA occurs in
the absence of membranes (Fig. 2 A, lane 2). To test whether
the requirement for intact membranes for formation of protease-resistant SecA 65-kDa and 30-kDa domains simply reflected the binding of SecA to SecYEG at the membrane
surface or rather indicated a more intimate relationship between SecA and the membrane, proteolytic protection of the
SecA 65-kDa domain was compared in translocation reactions
that were subjected to freezeythaw either before trypsin
treatment or, alternatively, in the presence of trypsin. In

FIG. 5. The protease-protected SecA 65-kDa domain inserts into
the membrane. [35S]SecA (5 3 104 cpm) was used in translocation
reactions with SecYEGDFyajC-enriched IMVs as described. After a
30-min incubation at 378C, the samples were transferred to ice and
either digested with trypsin (1 mgyml, 15 min; lane 1); incubated with
1% Triton X-100 and then digested with trypsin (lane 2); frozen in
liquid N2, thawed on ice (50 min), and then digested with trypsin (50
min; lane 3); or mixed with trypsin, immediately frozen, and thawed
and then incubated for 50 min (lane 4). The black arrow identifies the
protease-protected SecA 65-kDa domain, the white arrow identifies
the protease-protected SecA 30-kDa domain, and molecular mass
markers are shown on the right.
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samples that were frozen and thawed before the addition of
trypsin, protection of the SecA 65-kDa and 30-kDa domains
was unaffected, as compared with samples not subjected to a
cycle of freezeythaw (compare Fig. 5, lanes 1 and 3). When,
however, trypsin was added prior to membrane disruption by
a freezeythaw cycle, protease protection of the SecA-65 kDa
and 30-kDa domains was greatly diminished (lane 4). Freezey
thaw in the presence of protease allows access of the protease
into the IMV lumen during the reversible disruption of
membrane integrity. Any membrane-traversing SecA domain
would thus be available for digestion by the lumenally entrapped protease. The addition of protease subsequent to
freezeythaw would not allow access of the protease to the
interior of the resealed IMVs, thereby retaining the protease
inaccessibility of the SecA 65-kDa and 30-kDa fragments, as
observed. These observations are consistent with a model in
which the SecA 65-kDa and 30-kDa protease-protected fragments insert into and across the membrane. Other SecA
fragments (asterisks) survived proteolysis even when membrane integrity was lost (lanes 2 and 4) and thus presumably
originate from protease-resistant conformations of lipidassociated SecA.
SecDFyajC Slows Membrane Deinsertion of the SecA 65kDa Domain. It has been reported that the protease-protected
30-kDa domain of [125I]SecA undergoes cycles of membrane
insertion and deinsertion during preprotein translocation (15).
To determine whether cycling was also seen for the proteaseprotected 65-kDa SecA domain, translocation reactions were
initiated using [35S]SecA and IMVs prepared from E. coli
strain KM9. Fifteen minutes later, an excess of unlabeled SecA
was added and translocation was allowed to continue. Aliquots
were removed at successive intervals and the level of proteaseprotected [35S]SecA 65-kDa domain was determined (Fig. 6A).
Upon addition of unlabeled SecA, the level of the radiolabeled
protease-protected SecA 65-kDa domain rapidly decreased,
due to deinsertion of membrane-inserted [35S]SecA and subsequent exchange by the unlabeled SecA species. Similar
behavior was observed for the protease-protected SecA 30kDa domain, obtained from either [35S]SecA or [125I]SecA.
Indeed, the kinetics of deinsertion of the protease-protected
SecA 65-kDa and 30-kDa domains were identical and resembled those reported for the [125I]SecA 30-kDa fragment in
earlier studies (15). In contrast, the levels of nonsaturable,
lipid-associated [35S]SecA fragments, such as the 38-kDa fragment, were unaffected by an excess of unlabeled SecA.
When similar experiments were performed using IMVs
prepared from the SecYEGDFyajC-overproducing strain,
both the [35S]SecA 65-kDa and 30-kDa protease-protected
domains were chased at the same rate upon the addition of
excess unlabeled SecA (Fig. 6B). Furthermore, similar deinsertion kinetics were obtained for the protease-protected
[125I]SecA 30-kDa domain. Comparison of the rates of deinsertion in the two IMV preparations, however, revealed that
the SecYEGDFyajC-enriched IMVs required six times longer
to achieve the degree of deinsertion observed with KM9 IMVs.
To determine whether this difference in the SecA insertiony
deinsertion cycle was due to strain differences or to the
overexpression of the membrane-embedded Sec components,
preprotein translocation was initiated with [35S]SecA or
[125I]SecA and then continued in the presence of excess
unlabeled SecA, using IMVs prepared from wild-type BL21
cells or BL21 cells overexpressing either SecYEG or SecYEGDFyajC. The kinetics of SecA 65-kDa and 30-kDa domain
deinsertion were indistinguishable in wild-type and SecYEGenriched IMVs, and were similar to those obtained using IMVs
prepared from KM9 cells. In contrast, significantly longer
incubation periods were required for equivalent SecA 65-kDa
and 30-kDa domain deinsertion in IMVs containing enhanced
levels of SecYEGDFyajC (Fig. 6 C and D) consistent with
earlier reports that SecDFyajC stabilized the inserted SecA
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FIG. 6. The protease-protected SecA 65-kDa domain undergoes membrane insertion and deinsertion. Nine combined translocation reactions
containing [35S]SecA or [125I]SecA were performed in 0.9 ml. After a 15-min incubation at 378C, 210 mg of unlabeled SecA was added. At 5- to
10-min intervals, 100-ml aliquots were removed, transferred to ice, and treated with trypsin. The samples were TCA precipitated, acetone ‘‘washed,’’
heated in sample buffer (3 min, 958C), and examined by SDSyPAGE as above. SecA protease-protected fragments were quantitated
densitometrically and expressed as a percentage of the band intensities at the time of introduction of unlabeled SecA. In terms of absolute levels,
SecYEG-enriched IMVs contained higher amounts of protease-protected [35S]SecA 65-kDa and [125I]SecA 30-kDa domains as compared with
wild-type IMVs, whereas even higher levels of these membrane-inserted SecA fragments were observed in IMVs obtained from SecYEGDFyajCoverproducing cells. (A) Translocation reactions using KM9 IMVs. (B) Translocation reactions using SecYEGDFyajC-enriched IMVs. (C) Levels
of the protease-protected [35S]SecA 65-kDa fragment in IMVs prepared from wild-type BL21 cells or cells that overproduce either SecYEG or
SecYEGDFyajC. (D) Levels of the protease-protected [125I]SecA 30-kDa fragment in IMVs prepared from wild-type BL21 cells or cells that
overproduce either SecYEG or SecYEGDFyajC.

30-kDa domain (10, 30). As shown using IMVs from E. coli
KM9 (Fig. 6A), lipid-associated SecA, assayed by the 38-kDa
fragment (see Figs. 2, 4, and 5), did not deinsert in any of the
three BL21 IMV preparations (not shown).

DISCUSSION
SecA exists in several distinct conformational states. Differences in SecA proteolytic digestion patterns have been observed depending on whether the protein is in solution,
membrane-bound, or in the presence of ATP or preprotein
(31, 32). During translocation reactions in the presence of
SecYEG, nucleotide, and preprotein, a 30-kDa domain of
[125I]SecA is protected from proteolytic digestion through
insertion into the membrane (15). A closer examination of
[125I]SecA reveals, however, that only surface-accessible tyrosine residues in the C-terminal third of the protein are

radioiodinated. Metabolic [35S] labeling allows for a more
uniform labeling (Fig. 1) and, hence, a broader view of SecA
conformational states. With this more powerful probe, we now
confirm and extend our prior findings of the dynamics of the
30-kDa C-terminal domain of SecA, report that a 65-kDa
N-terminal domain of SecA has similar properties, and show
that the low-affinity association of SecA with lipid allows for
ATP-dependent conformational change(s) in which several
protease-resistant regions are generated.
Our studies of [35S]SecA are in full agreement with our
earlier studies employing [125I]SecA. When included in translocation reactions containing SecYEG, ATP, and preprotein,
both forms of labled SecA are able to translocate preprotein
and to protect a 30-kDa domain from externally added protease. The even distribution of radiolabel in [35S]SecA, however, allows for the detection of an additional proteaseprotected SecA 65-kDa domain. Protease protection of both

5580

Biochemistry: Eichler and Wickner

SecA 65-kDa and 30-kDa domains have the same requirements (i.e., SecYEG, nucleotide, preprotein, and physiological
temperature). In addition, the uniform distribution of radiolabel in [35S]SecA allows for differentiation between translocation-related, SecYEG-dependent SecA domains that are
protected from proteolysis by the membrane permeability
barrier and protease-resistant fragments that arise from nonspecific, low-affinity interactions between SecA and membrane lipids. Whereas SecA fragments of 65 kDa and 30 kDa
were generated only in the presence of SecYEG, ATP, and
preprotein, additional SecA fragments of 60, 38, 28, and 21
kDa were detected whenever reaction mixtures contained ATP
and either liposomes or membranes. Because the generation of
this latter set of SecA fragments is nonsaturable and did not
require either SecYEG or preprotein, it cannot be related to
translocation. Instead, it most likely results from proteolysis of
lipid-associated SecA molecules in ATP-dependent conformations. Indeed, nucleotide-dependent differences in vesiclebound SecA conformation have been reported (31, 32). Moreover, we have recently observed that two of these fragments,
namely the 60-kDa and the 38-kDa species, are readily labeled
by a lipid-restricted radioiodinated crosslinker (16). Although
lipid-associated SecA is abundant in vitro, the in vivo abundance and physiological roles of this form of SecA are unknown.
Like the [125I]SecA 30-kDa domain (15), the proteaseprotected [35S]SecA 65-kDa and 30-kDa domains insert into
the plane of the membrane and can be digested by protease
from the periplasmic side of the inner membrane. Other
researchers have also reported that SecA is accessible from the
periplasm, although these studies did not directly relate the
membrane-traversing SecA to translocation cycles (32, 33).
Our observations suggest that the translocation-related SecA
65-kDa and 30-kDa domains cross the membrane and lie
largely within the periplasmic space. Alternatively, the SecA
65-kDa and 30-kDa domains may insert far enough into the
membrane (possibly within the membrane-spanning domains
of SecYEG) to allow access of periplasmically localized protease to these SecA domains. The inserted 65-kDa and 30-kDa
domains may have different degrees of periplasmic exposure.
It is noteworthy that the membrane-inserted SecA 65-kDa and
30-kDa domains are largely shielded from the lipid phase of
the membrane (16).
As for SecA, transmembrane orientation has also been
proposed for the ATP-binding subunits of several other bacterial membrane transport systems. As members of the ATPbinding cassette (ABC) transporter superfamily, bacterial
permeases utilize ATP energy to mediate the trafficking of a
large variety of substrates. Eukaryotic members of the ABC
transporter superfamily include the cystic fibrosis transmembrane conductance regulator and the P-glycoprotein involved
in multidrug resistance (for review see refs. 34 and 35).
Bacterial permeases can be composed of both an integral
membrane protein complex and a hydrophilic ATP-binding
protein. Like SecA, these ATP-binding subunits were thought
to be peripheral membrane proteins. However, proteolytic
digestion experiments using inverted and right-side-out membrane vesicles have revealed transmembrane topologies for the
ATP-binding elements of the L-histidine transporter (HisP),
the maltose transporter (MalK), and the polysialic acid transporter (KpsT) (36–38). Notably, increased proteolysis was
observed with the E150G mutant of KpsT, which binds ATP
and substrate but cannot hydrolyse the bound ATP and is
thereby ‘‘locked’’ in a transmembrane state (38). This is similar
to preprotein translocase studies using the analagous D209N
SecA mutant, in which a blockage of ATP hydrolysis prevented
the deinsertion of membrane-inserted SecA (30).
The inserted SecA 65-kDa and 30-kDa domains can deinsert, as revealed by a replacement of [35S]SecA by unlabeled
SecA. Such replacement must entail both deinsertion of
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inserted [35S]SecA to the bound state at SecYEG sites on the
cytoplasmic surface of the membrane and dissociation from
these sites into solution. Because SecA is bound with high
affinity to the membranes at these SecYEG sites under
translocation conditions (8, 24), much of the deinserted and
bound [35S]SecA may reinsert rather than disassociate from
the membrane. Thus, our replacement assay provides only a
minimum estimate of the true rate of deinsertion. Earlier
studies using [125I]SecA reported that SecA membrane insertionydeinsertion cycling at SecYEG involves distinct ATP
binding and hydrolysis events and is regulated by SecDF (15,
30). In agreement with these findings, we find that the membrane-inserted SecA 65-kDa and 30-kDa domains show similar, rapid kinetics of deinsertion using IMVs from E. coli KM9
or BL21 wild-type strains. Overproduction of SecYEG provides more sites for SecA binding and insertion (24) but did not
affect the rate of chase of inserted SecA by unlabled SecA.
Overproduction of SecDFyajC, however, significantly slowed
the deinsertion of inserted SecA in the SecYEG-overproducing strain. The SecDFyajC-mediated effect on SecA deinsertion could be a result of stabilization of the inserted form of
SecA or slowing of an active deinsertion process.
Using [35S]SecA, Tai and coworkers (39) have also recently
examined the translocation-related SecA membrane insertionydeinsertion cycle. In most of their experiments, without
proteolysis to generate distinct lipid-bound and SecYEGinserted SecA fragments, Chen et al. could not observe chase
of membrane-inserted SecA. In our current study, membraneinserted [35S]SecA 65-kDa and 30-kDa domains could be
clearly chased upon addition of an excess of unlabeled SecA,
due to deinsertion and exchange of radiolabeled SecA by its
unlabeled counterpart, by using four different IMV preparations. The levels of nonspecifically bound, lipid-associated
[35S]SecA fragments remained unchanged during translocation reactions performed in the presence of excess unlabeled
SecA, reflecting the inability of these non-translocationrelated SecA fragments to dissociate from the membrane.
Without proteolysis to differentiate between the two species of
membrane-associated SecA, the abundant lipid-associated,
nonsaturatably bound SecA might have masked the chase of
SecA inserted at high-affinity SecYEG sites in the studies of
Chen et al. (39). These authors do not address the amount of
specifically bound, SecYEG-associated SecA in their system.
Indeed, when Chen et al. performed proteolysis, they observed
SecA 66-kDa and 28-kDa fragments that were maximally
protected from proteinase K digestion in the presence of ATP
and preprotein and that could be chased by excess unlabeled
SecA in an energy-dependent manner. These SecA 66-kDa and
28-kDa proteinase K-generated fragments most likely correspond to the 65-kDa and 30-kDa fragments produced by
trypsin digestion in the present study. Chen et al. (39) report
that a significant amount of 66-kDa fragment is found in the
supernatant. This may represent protease-protected membrane-inserted SecA fragments that dissociate because of
extensive digestion of SecYEG, the site of SecA insertion. We
have not examined this phenomenum in our system. In contrast
to the present study, Chen et al. (39) observed only a moderate
increase (less than 3-fold) in these protease-protected fragments upon addition of ATP and preprotein. The reasons for
this difference is unclear, though we find reproducible differences in the levels of protease-protected, membrane-inserted
fragments formed using IMVs generated from different strains
(not shown). We have shown that insertion of the translocation-related SecA 65-kDa and 30-kDa fragments occurs at
SecYEG (Fig. 4). In the present study, IMVs were prepared
from E. coli with overexpressed SecYEGDFyajC. These IMVs
display a 10- to 20-fold higher number of SecA binding sites as
compared with the BL21 wild-type strain (10). Use of these
IMVs highlights the presence of the protease-protected, translocation-related SecA 65-kDa and 30-kDa fragments. These
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bands were, however, also readily detected using IMVs prepared from either the wild-type BL21 parent strain (Fig. 4B)
or from E. coli strain KM9 (Fig. 6A).
In accord with its ability to interact with almost all of the
components required for preprotein translocation, SecA contains distinct regions dedicated to its different functions. SecA
contains a high-affinity ATP binding domain encompassing
amino acid residues 102–210 and a low-affinity ATP binding
domain between amino acid residues 503 and 653 (18, 19).
Only the high-affinity ATP binding site is essential for SecA
insertion and deinsertion, whereas the low-affinity domain is
required for preprotein translocation (30). One site for preprotein binding is located between amino acid residues 267 and
340 (12), whereas suppressors of signal-sequence mutations
have been mapped to SecA residues 111, 373, and 488 (40). The
protease-protected SecA 65-kDa domain, originating near the
N terminus and extending to near amino acid residue 570,
should contain both the high-affinity ATP binding site as well
as the proposed sites for preprotein binding. Indeed, the SecA
65-kDa domain was labeled in cross-linking studies using
[32P]ATP (not shown). It is possible, therefore, that membrane
insertion of the SecA 65-kDa domain plays a direct role in
preprotein translocation. Forward movement of preprotein
may involve the SecA membrane insertionydeinsertion cycle,
since ATP-driven translocation of preprotein occurs in a
stepwise manner (14, 41). In solution, SecA exists as a dimer
and may function as a dimer during active preprotein translocation (42, 43). Taken together, the protease-protected
N-terminal 65-kDa domain and the C-terminal 30-kDa domain
account for almost the full length of the 102-kDa SecA
monomer. It is, however, unclear whether the membraneinserted 65-kDa and 30-kDa domains are derived from the
same SecA molecule or whether they originate from different
halves of a single SecA dimer. Indeed, it is not yet known
whether both monomers of a SecA dimer insert into the
membrane. Until such questions are answered, it is difficult to
assess the relative contributions of the SecA 65-kDa and
30-kDa domains to translocation. Future experiments must
address these points for a clearer picture of the role of the SecA
membrane insertionydeinsertion cycle in preprotein translocation to emerge.
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